US Stock MarketDetailed Quotes
AIM AIM ImmunoTech
- 0.3700
- -0.0003-0.08%
Close Jul 22 16:00 ET
- 0.3699
- -0.0001-0.03%
Post 19:57 ET
21.14MMarket Cap-578P/E (TTM)
0.3900High0.3600Low233.26KVolume0.3700Open0.3703Pre Close86.03KTurnover0.44%Turnover RatioLossP/E (Static)57.14MShares0.722252wk High5.14P/B19.46MFloat Cap0.305452wk Low--Dividend TTM52.58MShs Float836.0000Historical High--Div YieldTTM8.10%Amplitude0.2910Historical Low0.3680Avg Price1Lot Size
AIM ImmunoTech Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -30.84%-4.82M | -32.03%-21.27M | -60.78%-9.76M | -14.15%-5.67M | 6.70%-2.16M | -33.43%-3.68M | -15.35%-16.11M | -5.64%-6.07M | -43.71%-4.97M | -34.63%-2.31M |
| Net income from continuing operations | -58.89%-5.82M | -48.94%-28.96M | -186.53%-12.58M | -22.41%-7.82M | -1.20%-4.91M | 4.16%-3.66M | -1.66%-19.45M | 24.92%-4.39M | -66.88%-6.39M | 17.44%-4.85M |
| Operating gains losses | 145.32%92K | -113.26%-218K | -386.52%-433K | -10.74%324K | -93.20%94K | -1,591.67%-203K | 623.57%1.64M | 55.94%-89K | 113.69%363K | -44.72%1.38M |
| Depreciation and amortization | 23.40%58K | -7.03%238K | -65.88%58K | 89.29%53K | 175.86%80K | 62.07%47K | -66.97%256K | -12.37%170K | -84.09%28K | -83.71%29K |
| Deferred tax | --0 | --0 | -4.86%900K | 2.75%-318K | -40.95%-327K | -34.21%-255K | 108.50%197K | 153.24%946K | -347.95%-327K | 19.44%-232K |
| Other non cash items | -83.78%6K | 142.21%287K | 267.57%136K | 347.83%103K | 101.48%11K | 640.00%37K | -124.48%-680K | 840.00%37K | -99.15%23K | -3,486.36%-745K |
| Change In working capital | 180.59%766K | 638.20%7.13M | 171.64%2.08M | 83.22%1.93M | 3.61%2.84M | 273.97%273K | 7.93%966K | -2,036.76%-2.91M | 1,050.45%1.06M | 116.75%2.74M |
| -Change in receivables | --1.18M | 1,505.71%492K | 29.89%-1.18M | ---9K | --1.68M | --0 | 93.23%-35K | -3.91%-1.68M | --0 | ---- |
| -Change in prepaid assets | 65.56%-62K | 201.32%153K | -111.17%-39K | 140.60%175K | 355.84%197K | -2,350.00%-180K | -109.26%-151K | -77.73%349K | -8,520.00%-431K | -279.07%-77K |
| -Change in payables and accrued expense | -187.39%-416K | 1,224.68%7.25M | 354.55%3.92M | 21.27%1.83M | 100.79%1.02M | 580.00%476K | 389.42%547K | -1,521.05%-1.54M | 1,722.58%1.51M | 268.12%508K |
| -Change in other current assets | ---- | -485.54%-486K | -4,760.00%-486K | --39K | ---- | ---- | ---83K | ---10K | --0 | ---- |
| -Change in other current liabilities | 360.87%60K | -139.83%-274K | -375.86%-138K | -343.48%-102K | -101.48%-11K | -360.00%-23K | 2,393.33%688K | -680.00%-29K | -76.92%-23K | 6,872.73%745K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -30.84%-4.82M | -32.03%-21.27M | -60.78%-9.76M | -14.15%-5.67M | 6.70%-2.16M | -33.43%-3.68M | -15.35%-16.11M | -5.64%-6.07M | -43.71%-4.97M | -34.63%-2.31M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -102.56%-158K | -107.57%-832K | -106.36%-214K | -234.40%-336K | -102.64%-204K | 77.46%-78K | 1,841.36%10.99M | 823.90%3.36M | 168.31%250K | 770.23%7.72M |
| Net PPE purchase and sale | --0 | -98.77%47K | -98.38%57K | -115.00%-45K | --6K | --29K | 1,769.61%3.81M | 50,300.00%3.51M | 3,850.00%300K | --0 |
| Net intangibles purchase and sale | -814.29%-50K | -216.22%-585K | -133.71%-208K | -770.00%-174K | -388.37%-210K | 121.21%7K | 68.75%-185K | 39.86%-89K | 74.68%-20K | ---43K |
| Net investment purchase and sale | 5.26%-108K | -104.00%-294K | -1.61%-63K | -290.00%-117K | --0 | 63.58%-114K | 3,128.40%7.36M | -111.95%-62K | 89.25%-30K | 666.30%7.76M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -102.56%-158K | -107.57%-832K | -106.36%-214K | -234.40%-336K | -102.64%-204K | 77.46%-78K | 1,841.36%10.99M | 823.90%3.36M | 168.31%250K | 770.23%7.72M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,729.00%2.83M | 506.25%485K | 147K | 832.00%233K | -90.91%5K | 100K | -99.02%80K | 0 | -16.67%25K | 101.16%55K |
| Net issuance payments of debt | --2.5M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | 229.00%329K | 506.25%485K | --147K | 832.00%233K | -90.91%5K | --100K | -99.39%80K | --0 | -16.67%25K | --55K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,729.00%2.83M | 506.25%485K | --147K | 832.00%233K | -90.91%5K | --100K | -99.02%80K | --0 | -16.67%25K | 101.16%55K |
| Net cash flow | ||||||||||
| Beginning cash position | -79.90%5.44M | -15.70%27.05M | -48.71%15.26M | -38.94%21.04M | -19.30%23.4M | -15.70%27.05M | -16.64%32.09M | -20.32%29.76M | -16.26%34.45M | -40.56%28.99M |
| Current changes in cash | 41.39%-2.14M | -328.85%-21.61M | -263.08%-9.83M | -23.03%-5.77M | -143.14%-2.36M | -17.85%-3.66M | 21.35%-5.04M | 48.52%-2.71M | -23.73%-4.69M | 171.59%5.46M |
| End cash Position | -85.92%3.3M | -79.90%5.44M | -79.90%5.44M | -48.71%15.26M | -38.94%21.04M | -19.30%23.4M | -15.70%27.05M | -15.70%27.05M | -20.32%29.76M | -16.26%34.45M |
| Free cash flow | -32.20%-4.87M | -33.41%-21.85M | -59.45%-9.96M | -17.38%-5.86M | -0.21%-2.36M | -31.85%-3.68M | -12.20%-16.38M | -5.83%-6.24M | -40.74%-4.99M | -35.09%-2.36M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
